[1]
M. van Meekeren, “A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma”, AO, vol. 60, no. 12, pp. 1557–1564, Sep. 2021.